Our studies revealed a novel hypertrophic signalling pathway (miR‐103/TRPV3/autophagy), and manipulation of this signalling axis may provide innovative approaches to prevent cardiac hypertrophy. Here, TRPV3 is linked to cardiac hypertrophy.